In a study of 17,000 Medicare beneficiaries with mild cognitive impairment or dementia, non-Hispanic white older adults were more likely than Asian, Black or Hispanic older adults to have elevated cortical amyloid, as measured by PET. These findings have important implications for the use of amyloid-targeting therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Chen, C. & Zissimopoulos, J. M. Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States. Alzheimers Dement. (NY) 4, 510–520 (2018).
Wilkins, C. H. et al. Racial and ethnic differences in amyloid PET positivity in individuals with mild cognitive impairment or dementia: a secondary analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) cohort study. JAMA Neurol. https://doi.org/10.1001/JAMANEUROL.2022.3157 (2022).
Rabinovici, G. D. et al. Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia. J. Am. Med. Assoc. 321, 1286–1294 (2019).
Gottesman, R. F. et al. The ARIC-PET amyloid imaging study: brain amyloid differences by age, race, sex, and APOE. Neurology 87, 473–480 (2016).
Meeker, K. L. et al. Socioeconomic status mediates racial differences seen using the AT(N) framework. Ann. Neurol. 89, 254–265 (2021).
Deters, K. D. et al. Amyloid PET imaging in self-identified non-hispanic black participants of the Anti-Amyloid in Asymptomatic Alzheimer’s disease (A4) study. Neurology 96, e1491–e1500 (2021).
Barnes, L. L. et al. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology 85, 528–534 (2015).
Gleason, C. E. et al. Association between enrollment factors and incident cognitive impairment in Blacks and whites: data from the Alzheimer’s Disease Center. Alzheimers Dement. 15, 1533–1545 (2019).
Powell, W. R. et al. Association of neighborhood-level disadvantage with Alzheimer disease neuropathology. JAMA Netw. Open 3, e207559 (2020).
Gottesman, R. F. et al. Association between midlife vascular risk factors and estimated brain amyloid deposition. J. Am. Med. Assoc. 317, 1443–1450 (2017).
Acknowledgements
The authors are supported by the Intramural Research Program of the NIH, National Institute on Aging.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Dark, H.E., Walker, K.A. New IDEAS about amyloid, race and dementia disparities. Nat Rev Neurol 19, 5–6 (2023). https://doi.org/10.1038/s41582-022-00748-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-022-00748-0
